Pharmacokinetics of ibuprofen in man IV: absorption and disposition

J G Wagner, K S Albert, G J Szpunar, G F Lockwood, J G Wagner, K S Albert, G J Szpunar, G F Lockwood

Abstract

Fifteen normal male volunteers received 400, 800, and 1200 mg doses of ibuprofen as 1, 2, or 3 tablets, respectively, in crossover fashion, then 420 mg in solution form during the fourth week. Plasma concentration of ibuprofen was measured by an HPLC method. Individual subject concentration-time (C,t) data following the solution were analyzed by two different methods, and results unequivocally indicated the open two compartment model with first order absorption. However, the computer fitting of both arithmetic and geometric mean concentrations led to a different model. A method was developed to obtain absorption data (fraction of drug absorbed, Fa, versus time) for a multicompartmental system from oral data alone, without intravenous data. The method assumes that Vp is constant intrasubject and that absorption is complete following administration of both the solution and tablets. The method was successfully applied to the ibuprofen tablet data. It was shown also that such a method is necessary to obtain ibuprofen absorption data since intrasubject variation of the microscopic rate constants k12, k21, and kel (as reflected by the intrasubject variation of the hybrid rate parameters lambda 1 and lambda 2 or beta and alpha) is of the same order of magnitude as intersubject variation. Absorption of ibuprofen from tablets was shown not to be simple first order as for the solution. The absorption profiles following one tablet were S-shaped, while those following 2 or 3 tablets had partial linear segments indicating zero order absorption.

References

    1. J Pharm Sci. 1981 Aug;70(8):944-5
    1. Drugs. 1971;2(5):416-46
    1. J Chromatogr. 1981 Nov 13;226(1):183-90
    1. J Pharm Sci. 1981 Dec;70(12):1347-9
    1. J Pharm Sci. 1978 May;67(5):627-30
    1. J Pharm Sci. 1983 Jul;72(7):838-42
    1. J Pharmacokinet Biopharm. 1983 Oct;11(5):469-82
    1. J Pharm Sci. 1963 Jun;52:610-1
    1. J Pharm Sci. 1974 Feb;63(2):219-21
    1. J Chromatogr. 1979 Apr 21;172:516-9
    1. Am J Med. 1984 Jul 13;77(1A):47-50
    1. Biochem Pharmacol. 1979 Mar 1;28(5):675-8
    1. Mol Pharmacol. 1980 Nov;18(3):421-6
    1. Clin Pharmacol Ther. 1983 Jul;34(1):97-103
    1. J Pharm Sci. 1968 Jun;57(6):918-28
    1. Xenobiotica. 1973 Sep;3(9):589-98
    1. Clin Pharmacol Ther. 1981 Apr;29(4):487-92
    1. J Chromatogr. 1982 Nov 12;232(2):335-43
    1. J Pharm Sci. 1967 Dec;56(12):1686
    1. J Pharm Sci. 1980 May;69(5):590-2
    1. J Chromatogr. 1979 Feb 11;170(1):278-81
    1. J Chromatogr. 1980 Mar 21;190(1):119-28

Source: PubMed

3
Sottoscrivi